Ireland - English - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals (ireland) ltd - calcium gluconate - solution for injection - 10 %w/v, 1 grams

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - rocuronium bromide, quantity: 100 mg - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; sodium acetate trihydrate; glacial acetic acid; water for injections - adjunct to general anaesthesia to facilitate endotracheal intubation during routine induction, to provide muscle relaxation and to facilitate mechanical ventilation in adults, children and infants over 1 month of age.. adjunct to general anaesthesia to facilitate endotracheal intubation during rapid sequence induction when suxamethonium is contraindicated, however, this has not been studied in infants and children.. adjunct in the intensive care unit (icu) to facilitate mechanical ventilation.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - fluconazole, quantity: 2 mg/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium chloride - fluconazole sandoz injection is indicated in adults and children for the following conditions only if fluconazole can not be administered orally. for treatment of cryptococcal meningitis in patients who are unable to tolerate amphotericin b. note. data suggest that the clinical efficacy of fluconazole is lower than that of amphotericin b in the treatment of the acute phase of cryptococcal meningitis. maintenance therapy to prevent relapse of cryptococcal meningitis in patients with acquired immune deficiency syndrome (aids). treatment of oropharyngeal and oesophageal candidiasis in aids and other immunosuppressed patients. secondary prophylaxis of oropharyngeal candidiasis in patients with human immunodeficiency virus (hiv) infection. serious and life threatening candida infections in patients who are unable to tolerate amphotericin b. note. it remains to be shown that fluconazole is as effective as amphotericin b in the treatment of serious and life threatening candida infections. until such data are available, amphotericin b remains the drug of choice. vaginal candidiasis, when topical therapy has failed. treatment of extensive tinea corporis, extensive tinea cruris and extensive tinea pedis infections in immunocompetent patients in whom topical therapy is not a practical treatment option. usually, topical therapy should be attempted first because oral and intravenous therapy has a less favourable ratio of benefits to risks. (see adverse effects.)

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - calcium folinate, quantity: 54 mg (equivalent: folinic acid, qty 50 mg) - injection, solution - excipient ingredients: sodium chloride; water for injections - neutralising the immediate toxic effects of folic acid antagonists, eg methotrexate. treatment of megaloblastic anaemias due to folic acid deficiency, eg in sprue, malnutrition, pregnancy, infancy, liver disease and malabsorption syndromes. folinic acid rescue, ie using calcium folinate in conjunction with folic acid antagonists, eg methotrexate, to minimise systemic toxicity. indications as at 13 jan 05 : leucovorin calcium has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions. leucovorin calcium has also shown good results in reducing the toxicity and circumventing the effect of folic acid antagonists, if therapeutically desired.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - calcium folinate, quantity: 324.1 mg (equivalent: folinic acid, qty 300 mg) - injection - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections; sodium chloride - leucovorin calcium has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency.this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver disease, sprue and malnutrition. it is not more effective than folic acid for these conditions. leucovorin calcium has also shown good results in reducing the toxicity and circumventing the effect of folic acid antagonists, if therapeutically desired.

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

coophavet - calcium gluconate, magnesium hypophosphite, boric acid - solution for injection - ca.gluconate 28g, mg hypophosphate 9g, boric acid 5.75g - 1.increase muscle contraction, reduce farrowing period, reduce stillborn & metritis 2.increase lactation, reduce mastitis & agalactia

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - calcium folinate 8.1 mg/ml equivalent to 7.5 mg folinic acid;  ;   - solution for injection - 15 mg/2ml - active: calcium folinate 8.1 mg/ml equivalent to 7.5 mg folinic acid     excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - calcium leucovorin has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions. calcium leucovorin also has shown good results in reducing the toxicity and circumventing the effect of folic acid antagonists, if therapeutically desired. use in combination with 5-fluorouracil in the treatment of advanced colorectal carcinoma.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - calcium folinate 10.5 mg/ml;  ;   - solution for injection - 300 mg/30ml - active: calcium folinate 10.5 mg/ml     excipient: sodium chloride water for injection - calcium leucovorin has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions. calcium leucovorin also has shown good results in reducing the toxicity and circumventing the effect of folic acid antagonists, if therapeutically desired. use in combination with 5-fluorouracil in the treatment of advanced colorectal carcinoma.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - calcium folinate 10.5 mg/ml (4% overage);  ;   - solution for injection - 50 mg/5ml - active: calcium folinate 10.5 mg/ml (4% overage)     excipient: sodium chloride water for injection - calcium leucovorin has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions. calcium leucovorin also has shown good results in reducing the toxicity and circumventing the effect of folic acid antagonists, if therapeutically desired. use in combination with 5-fluorouracil in the treatment of advanced colorectal carcinoma.

Israel - English - Ministry of Health

teva medical marketing ltd. - calcium chloride dihydrate; potassium chloride; sodium chloride; sodium lactate - solution for infusion - sodium lactate 0.32 %w/v; calcium chloride dihydrate 0.027 %w/v; potassium chloride 0.04 %w/v; sodium chloride 0.6 %w/v - calcium chloride - calcium chloride - source of water and electrolytes. regulation or maintenance of metabolic acidosis ( except lactic acidosis).